Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variability

25 May 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Neurogenetic and Muscular Disorders Research
Share to RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 21610752
DOI: 10.1038/ejhg.2011.89

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variabilityPMID 21610752Read ↗

Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblastsSemantic proximity Read ↗

Patient-specific responses to <i>SMN2</i> splice-modifying treatments in spinal muscular atrophy fibroblastsSemantic proximity Read ↗

Spinal muscular atrophy.Semantic proximity Read ↗

Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy TherapySemantic proximity Read ↗

Combining multi-omics and drug perturbation profiles to identify novel treatments that improve disease phenotypes in spinal muscular atrophySemantic proximity Read ↗

Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in GermanySemantic proximity Read ↗

Selecting disease‐modifying medications in 5q spinal muscular atrophySemantic proximity Read ↗

New treatments in spinal muscular atrophy.Semantic proximity Read ↗

Pharmacokinetics, pharmacodynamics, and efficacy of a small-moleculeSMN2splicing modifier in mouse models of spinal muscular atrophySemantic proximity Read ↗

Spinal muscular atrophy.Semantic proximity Read ↗

Spinal muscular atrophy - new therapies, new challenges.Semantic proximity Read ↗

Treatment of 5q-spinal muscular atrophy with nusinersen in Southern China: A single center retrospective studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.